Sponsored Webinar: Changing the Paradigm of Patient Care with New Rapid Antimicrobial Susceptibility Testing Technologies
November 7 @ 11:00 am - 12:00 pm
Date: November 7, 2023
Time: 11:00 – 12:00 pm ET / 8:00 – 9:00 am PT
Bloodstream infection is a medical emergency that necessitates promptly administering appropriate antibiotics. The current laboratory procedure for antimicrobial susceptibility testing (AST) involves a subculture of organisms from positive blood bottles, followed by a legacy AST system testing or disk diffusion method. New rapid antimicrobial susceptibility testing (rAST) technologies have been developed in recent years that eliminate the subculture step, preparing the samples directly from positive blood cultures, effectively reducing the time-to-result by several hours to one day. In this sponsored webinar, the presenters will discuss the importance of rAST and the clinical and financial benefits of rAST for blood cultures and septic patients, the necessity to use the current breakpoints to report MIC results, as well as the clinical evaluation results from the Selux Direct Positive Blood Culture AST system.
James Lewis, PharmD
Infectious Disease Pharmacist, Oregon Health and Science University
Thomas Kirn, MD, PhD
Professor, Department of Pathology and Medicine, Rutgers Robert Wood Johnson Medical School
Sepsis Alliance gratefully acknowledges the support provided for this webinar by Selux.